JW (CAYMAN) THERAPEUTICS CO. LTD |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.9 HKD | -1.04% |
|
+4.40% | -15.93% |
| 20/03 | JW (Cayman) Therapeutics Shrinks Loss in Fiscal 2023 | MT |
| 20/03 | JW Therapeutics Co. Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on JW (Cayman) Therapeutics Co. Ltd
Price target over the last 5 years
History of analyst recommendation changes
a88f2ebe977.agXhp3QS-Y8TkxGwIw2X7blHIigraVoZL8wYrxBoNso.BjGyxk14psd5-SmGFVv42vwuSnp0PD1_dq1OzXw3Rf87a9GUEHycunThWA~60da707b606f2e19b97ecaf13fdacaa1
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.752
CNY
Average target price
2.508
CNY
Spread / Average Target
+43.16%
High Price Target
3.285
CNY
Spread / Highest target
+87.51%
Low Price Target
2.025
CNY
Spread / Lowest Target
+15.59%
Consensus detail
Consensus revision (last 18 months)
Analysts covering JW (Cayman) Therapeutics Co. Ltd
| UBS |
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- 2126 Stock
- Consensus JW (Cayman) Therapeutics Co. Ltd